Digoxin Tablets

DRUG3 trials

Sponsors

Jiangsu HengRui Medicine Co., Ltd., Shandong Suncadia Medicine Co., Ltd., Guangdong Raynovent Biotech Co., Ltd

Conditions

Chronic Hepatitis BObesityOverweight

Phase 1

A Pharmacokinetic Study to Evaluate the Drug Interaction Between HRS5091 and Probe Drugs in Healthy Volunteers

CompletedNCT05273775

Jiangsu HengRui Medicine Co., Ltd.Chronic Hepatitis B

Start: 2022-04-29End: 2022-06-23Updated: 2022-12-23

A Study to Evaluate the Drug Interactions of HRS-7535 With Acetaminophen, Digoxin, Rosuvastatin, and Omeprazole in Obese or Overweight Subjects

RecruitingNCT07269756

Shandong Suncadia Medicine Co., Ltd.Obesity, Overweight

Start: 2025-12-08End: 2026-02-28Target: 40Updated: 2025-12-31

Drug-durg Interaction of RAY1225 With Warfarin, Atorvastatin, Metformin and Digoxin

Active, not recruitingNCT07362030

Guangdong Raynovent Biotech Co., LtdObesity

Start: 2025-04-14End: 2026-03-30Updated: 2026-01-23